Central Abdominal Bulging
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Evofem BiosciencesCA - San Diego
2 programs2
LIPO-202Phase 31 trial
LIPO-202Phase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Evofem BiosciencesLIPO-202
Evofem BiosciencesLIPO-202
Clinical Trials (2)
Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202
Start: Jun 2015Est. completion: Feb 2016
Phase 3Terminated
Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)
Start: Apr 2015Est. completion: Oct 2015
Phase 3Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space